Fresenius Historical Cash Flow
| FMS Stock | USD 22.38 0.23 1.04% |
Analysis of Fresenius Medical cash flow over time is an excellent tool to project Fresenius Medical Care future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 2.3 B or Change In Working Capital of 530.4 M as it is a great indicator of Fresenius Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.
Fresenius |
About Fresenius Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Fresenius balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Fresenius's non-liquid assets can be easily converted into cash.
Fresenius Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Fresenius Medical Care to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Fresenius Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Fresenius Medical Care financial statement analysis. It represents the amount of money remaining after all of Fresenius Medical Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Fresenius Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Fresenius Medical's End Period Cash Flow is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 30.7 M in 2025, despite the fact that Other Cashflows From Financing Activities is likely to grow to (295.8 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 1.4B | 684.6M | 787.3M | 1.0B | Dividends Paid | 395.6M | 328.6M | 377.9M | 221.6M |
Fresenius Medical cash flow statement Correlations
Click cells to compare fundamentals
Fresenius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fresenius Medical cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (599.8M) | (366.0M) | 6.5M | 20.2M | 23.2M | 24.3M | |
| Change To Inventory | (355.8M) | (48.5M) | (204.3M) | (13.1M) | (11.8M) | (12.4M) | |
| Change In Cash | 73.8M | 400.1M | (207.9M) | 153.4M | 176.5M | 185.3M | |
| Free Cash Flow | 2.1B | 806M | 756M | 1.9B | 2.2B | 2.3B | |
| Change In Working Capital | 1.0B | (354M) | (566M) | 561.3M | 505.1M | 530.4M | |
| Begin Period Cash Flow | 1.0B | 1.1B | 1.5B | 1.3B | 1.5B | 1.5B | |
| Other Cashflows From Financing Activities | (693.5M) | 2.8B | 1.6B | (270.8M) | (311.4M) | (295.8M) | |
| Depreciation | 1.8B | 1.6B | 1.8B | 1.8B | 2.0B | 2.1B | |
| Other Non Cash Items | 1.8B | 1.6B | 41.1M | (327.3M) | (376.4M) | (357.5M) | |
| Dividends Paid | 351.2M | 392.5M | 395.6M | 328.6M | 377.9M | 221.6M | |
| Capital Expenditures | 2.1B | 1.7B | 1.4B | 684.6M | 787.3M | 1.0B | |
| Total Cash From Operating Activities | 4.2B | 2.5B | 2.2B | 2.6B | 3.0B | 1.5B | |
| Net Income | 1.4B | 1.2B | 895M | 732.5M | 842.3M | 857.9M | |
| Total Cash From Financing Activities | (2.7B) | (1.0B) | (1.6B) | (1.9B) | (1.7B) | (1.6B) | |
| End Period Cash Flow | 1.1B | 1.5B | 1.3B | 1.4B | 1.6B | 1.7B | |
| Change To Netincome | (173.6M) | 246.4M | 32.6M | (98.1M) | (88.3M) | (83.9M) | |
| Stock Based Compensation | (1.9B) | (1.7B) | (5.9M) | 32.5M | 29.3M | 30.7M | |
| Change To Account Receivables | 71.7M | (163.2M) | (46.7M) | (151.8M) | (136.7M) | (143.5M) | |
| Investments | (1.3B) | (61.6M) | (734.7M) | (672.7M) | (605.4M) | (635.7M) | |
| Net Borrowings | 700.0M | (1.6B) | (358.9M) | (1.0B) | (920.7M) | (874.7M) | |
| Total Cashflows From Investing Activities | (3.3B) | (1.3B) | (1.2B) | (734.7M) | (844.9M) | (887.2M) | |
| Change To Operating Activities | (46.1M) | (178.5M) | 164.2M | 154.0M | 177.1M | 186.0M | |
| Other Cashflows From Investing Activities | (249.7M) | (309.5M) | 35.6M | 16.1M | 14.5M | 15.3M | |
| Change To Liabilities | (164.8M) | 1.4B | (364.0M) | (356.8M) | (321.1M) | (305.1M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.